Melody Harris - 21 Feb 2025 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Signature
/s/ Ali Olivo, Attorney-in-Fact
Issuer symbol
NEO
Transactions as of
21 Feb 2025
Net transactions value
$0
Form type
4
Filing time
25 Feb 2025, 16:40:26 UTC
Previous filing
16 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Options Exercise $0 +8,443 +8.2% $0.000000 111,811 23 Feb 2025 Direct F1, F2
transaction NEO Common Stock Tax liability $0 -2,056 -1.8% $0.000000 109,755 23 Feb 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Stock Option (Right to Buy) Award $0 +143,266 $0.000000 143,266 21 Feb 2025 Common Stock 143,266 $13.05 Direct F4, F5
transaction NEO Restricted Stock Unit Award $0 +84,317 $0.000000 84,317 21 Feb 2025 Common Stock 84,317 $0.000000 Direct F6, F7
transaction NEO Restricted Stock Unit Options Exercise $0 -8,443 -33% $0.000000 16,886 23 Feb 2025 Common Stock 8,443 $0.000000 Direct F7, F8
holding NEO Stock Option (Right to Buy) 201,613 21 Feb 2025 Common Stock 201,613 $9.24 Direct F9
holding NEO Stock Option (Right to Buy) 39,683 21 Feb 2025 Common Stock 39,683 $19.65 Direct F10
holding NEO Restricted Stock Unit 14,136 21 Feb 2025 Common Stock 14,136 $0.000000 Direct F7, F11
holding NEO Performance Stock Unit 21,204 21 Feb 2025 Common Stock 21,204 $0.000000 Direct F7, F12
holding NEO Stock Option (Right to Buy) 42,344 21 Feb 2025 Common Stock 42,344 $16.45 Direct F13
holding NEO Performance Stock Unit 25,330 21 Feb 2025 Common Stock 25,330 $0.000000 Direct F7, F14
holding NEO Stock Option (Right to Buy) 19,984 21 Feb 2025 Common Stock 19,984 $13.96 Direct F15
holding NEO Performance Stock Unit 11,939 21 Feb 2025 Common Stock 11,939 $0.000000 Direct F7, F16
holding NEO Restricted Stock Unit 11,939 21 Feb 2025 Common Stock 11,939 $0.000000 Direct F7, F17
holding NEO Restricted Stock Unit 59,382 21 Feb 2025 Common Stock 59,382 $0.000000 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.
F2 This balance includes 548 shares that were acquired pursuant to NeoGenomics' Employee Stock Purchase Plan. The shares were acquired in transactions exempt from Section 16b-3.
F3 Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.
F4 This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%.
F5 On February 21, 2025, Ms. Harris was granted 143,266 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F6 On February 21, 2025, Ms. Harris was granted 84,317 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F7 Once vested, the shares of common stock are not subject to expiration.
F8 On February 23, 2024, Ms. Harris was granted 25,329 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F9 On January 1, 2023, Ms. Harris was granted 201,613 stock options. These options vest ratably over the first four anniversary dates of the grant date.
F10 On May 11, 2023, Ms. Harris was granted 39,683 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F11 On May 11, 2023, Ms. Harris was granted 21,204 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.
F12 On May 11, 2023, Ms. Harris was granted 21,204 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to theperformance criteria is31,806. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stockover the 20-day trailing trading period at theapplicable measurement dates, subject to continued service with the Company.
F13 On February 23, 2024, Ms. Harris was granted 42,344 stock options. These options vest ratably over the first three anniversary dates of the grant date
F14 On February 23, 2024, Ms. Harris was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant tothe performance criteria is37,996. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company'scommon stock over the 20-day trailing trading period atthe applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based onthe achievement of certain revenue growth goals based on the achievement of thecumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
F15 On May 2, 2024, Ms. Harris was granted 19,984 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F16 On May 2, 2024, Ms. Harris was granted 11,939 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to theperformance criteria is17,909. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company'scommon stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based onthe achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.
F17 On May 2, 2024, Ms. Harris was granted 11,939 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.